You are viewing the site in preview mode

Skip to main content

Peer Review reports

From: Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report

Original Submission
14 Jan 2021 Submitted Original manuscript
20 Feb 2021 Reviewed Reviewer Report
7 Mar 2021 Reviewed Reviewer Report
11 Mar 2021 Author responded Author comments - Kai Conrad Cecil Johnson
Resubmission - Version 2
11 Mar 2021 Submitted Manuscript version 2
18 Mar 2021 Reviewed Reviewer Report
19 Mar 2021 Reviewed Reviewer Report
23 Mar 2021 Author responded Author comments - Kai Conrad Cecil Johnson
Resubmission - Version 3
23 Mar 2021 Submitted Manuscript version 3
Publishing
26 Mar 2021 Editorially accepted
1 Apr 2021 Article published 10.1186/s12894-021-00825-4

You can find further information about peer review here.

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us